HealthEquity (NASDAQ:HQY) Trading Up 2.9%

HealthEquity, Inc. (NASDAQ:HQY)’s share price was up 2.9% on Tuesday . The stock traded as high as $69.93 and last traded at $69.77. Approximately 161,272 shares changed hands during trading, a decline of 75% from the average daily volume of 648,121 shares. The stock had previously closed at $67.81.

Wall Street Analyst Weigh In

Several analysts have weighed in on HQY shares. Deutsche Bank Aktiengesellschaft lifted their price objective on HealthEquity from $71.00 to $72.00 and gave the company a “buy” rating in a research report on Thursday, September 7th. StockNews.com assumed coverage on shares of HealthEquity in a report on Thursday, August 17th. They issued a “hold” rating for the company. Royal Bank of Canada boosted their price objective on shares of HealthEquity from $75.00 to $77.00 and gave the stock an “outperform” rating in a report on Wednesday, September 6th. Finally, Barrington Research boosted their target price on shares of HealthEquity from $80.00 to $85.00 and gave the company an “outperform” rating in a research note on Wednesday, September 6th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $82.67.

HealthEquity Stock Performance

The firm has a market capitalization of $5.94 billion, a PE ratio of 460.20, a price-to-earnings-growth ratio of 2.46 and a beta of 0.79. The company has a current ratio of 4.09, a quick ratio of 4.09 and a debt-to-equity ratio of 0.45. The business’s 50 day simple moving average is $66.80 and its two-hundred day simple moving average is $61.61.

Insider Transactions at HealthEquity

In other news, CEO Jon Kessler sold 19,588 shares of the company’s stock in a transaction on Monday, June 26th. The stock was sold at an average price of $60.12, for a total value of $1,177,630.56. Following the completion of the sale, the chief executive officer now directly owns 6,129 shares in the company, valued at approximately $368,475.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, CEO Jon Kessler sold 19,588 shares of the company’s stock in a transaction on Monday, June 26th. The stock was sold at an average price of $60.12, for a total value of $1,177,630.56. Following the completion of the sale, the chief executive officer now directly owns 6,129 shares in the company, valued at approximately $368,475.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Tyson D. Murdock sold 2,844 shares of the company’s stock in a transaction on Thursday, September 7th. The stock was sold at an average price of $71.35, for a total value of $202,919.40. Following the completion of the sale, the insider now owns 70,389 shares of the company’s stock, valued at $5,022,255.15. The disclosure for this sale can be found here. 2.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of HQY. Quadrant Capital Group LLC boosted its holdings in shares of HealthEquity by 62.7% during the 4th quarter. Quadrant Capital Group LLC now owns 540 shares of the company’s stock valued at $33,000 after purchasing an additional 208 shares during the last quarter. Covestor Ltd increased its position in shares of HealthEquity by 247.3% during the second quarter. Covestor Ltd now owns 580 shares of the company’s stock worth $37,000 after acquiring an additional 413 shares during the period. Castleview Partners LLC purchased a new position in shares of HealthEquity during the second quarter worth approximately $39,000. Coppell Advisory Solutions LLC purchased a new position in shares of HealthEquity during the second quarter worth approximately $48,000. Finally, Assetmark Inc. increased its position in shares of HealthEquity by 24.5% during the first quarter. Assetmark Inc. now owns 940 shares of the company’s stock worth $55,000 after acquiring an additional 185 shares during the period. Institutional investors own 98.46% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.